Site Specificity of Atherosclerosis: Site-Selective Responses to Atherosclerotic Modulators

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 24, Issue 1, 2004, Pages 12-22

  VanderLaan, Paul A ^a   Reardon, Catherine A ^a   Getz, Godfrey S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Atherosclerosis; Hemodynamics; Risk factors; Site specificity

Indexed keywords

ALPHA TOCOPHEROL; AMIDE; APOLIPOPROTEIN A1; APOLIPOPROTEIN B100; APOLIPOPROTEIN B48; FENOFIBRATE; GAMMA INTERFERON; HYPOCHOLAMIDE; INTERLEUKIN 4; LIPOXYGENASE; OXIDIZED LOW DENSITY LIPOPROTEIN; PROBUCOL; UBIDECARENONE; UNCLASSIFIED DRUG;

ATHEROSCLEROSIS; BONE MARROW TRANSPLANTATION; CARDIOVASCULAR RISK; GAMMA IRRADIATION; GENDER; GENETICS; HEMODYNAMICS; HUMAN; HYPERCHOLESTEROLEMIA; IMMUNE STATUS; MOUSE; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK FACTOR; SHORT SURVEY;

ADOLESCENT; ADULT; ANIMALS; ARTERIOSCLEROSIS; CELL ADHESION MOLECULES; DISEASE SUSCEPTIBILITY; FEMALE; HEMORHEOLOGY; HUMANS; MALE; MICE; MODELS, ANIMAL; MODELS, BIOLOGICAL; ORGAN SPECIFICITY; OXIDATIVE STRESS; RISK FACTORS; SEX FACTORS;

EID: 0345861777     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000105054.43931.f0     Document Type: Short Survey

References (117)

1. Mahley RW, Rall SC. Type III hypedipoproteinemia (dysbetalipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease. 7th ed. New York, NY: McGraw-Hill; 1995;1953-1980.
2. Morganroth J, Levy RI, Fredrickson DS. The biochemical, clinical, and genetic features of type III hyperlipoproteinemia. Ann Intern Med. 1975;82:158-174.
3. Fazio S, Sanan DA, Lee YL, Ji ZS, Mahley RW, Rall SC. Susceptibility to diet-induced atherosclerosis in transgenic mice expressing a dysfunctional human apolipoprotein E (arg112, cys142). Arterioscler Thromb. 1994;14:1873-1879.
4. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA. 2002;287:2570-2581.
5. Newman AB, Siscovick DS, Manolio TA, et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Circulation. 1993;88:837-845.
6. Uusitupa MI, Niskanen LK, Siitonen O, Voutilainen E, Pyorala K. 5-Year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects. Circulation. 1990;82:27-36.
7. Schaper NC, Habuurs-Franssen MH, Huijberts MSP. Peripheral vascular disease and type 2 diabetes mellitus. Diabetes Metab Res Rev. 2000;16(suppl 1):S11-S15.
8. Gnasso A, Irace C, Carallo C, et al. In vivo association between low wall shear stress and plaque in subjects with asymmetrical carotid atherosclerosis. Stroke. 1997;28:993-998.
9. Irace C, Carallo C, Crescenzo A, et al. NIDDM is associated with lower wall shear stress of the common carotid artery. Diabetes. 1999;48:193-197.
10. McGill HC Jr, McMahan CA. Determinants of atherosclerosis in the young. Am J Cardiol. 1998;82:30T-36T.
11. McGill HC Jr, McMahan CA, Zieske AW, et al. Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth. Arterioscler Thromb Vasc Biol. 2000;20:1998-2004.
12. McGill HC Jr, McMahan CA, Herderick EE, et al. Effects of coronary heart disease risk factors on atherosclerosis of selected regions of the aorta and right coronary artery: PDAY Research Group: Pathobiological Determinants of Atherosclerosis in Youth. Arterioscler Thromb Vasc Biol. 2000;20:836-845.
13. Stary HC. Lipid and macrophage accumulations in arteries of children and the development of atherosclerosis. Am J Clin Nutr. 2000;72:1297S-1306S.
14. Sims FH. Discontinuities in the internal elastic lamina: a comparison of coronary and internal mammary arteries. Artery. 1985;13:127-143,
15. Caro CG, Fitz-Gerald JM, Schroter RC. Arterial wall shear and distribution of early atheroma in man. Nature. 1969;223:1159-1161.
16. Zarins CK, Giddens DP, Bharadvaj BK, Sottiurai VS, Mabon RF, Glagov S. Carotid bifurcation atherosclerosis: quantitative correlation of plaque localization with flow velocity profiles and wall shear stress. Circ Res. 1983;53:502-514.
17. Ku DN, Giddens DP, Zarins CK, Glagov S. Pulsatile flow and atherosclerosis in the human carotid bifurcation: positive correlation between plaque localization and low oscillating shear stress. Arteriosclerosis. 1985;5:293-302.
18. Moore JE, Ku DN, Zarins CK, Glagov S. Pulsatile flow visualization in the abdominal aorta under different physiologic conditions: implications for increased susceptibility to atherosclerosis. J Biomech Eng. 1992;114:391-397.
19. Stary HC, Composition and classification of human atherosclerotic lesions. Virchows Arch A Pathol Anat Histopathol. 1992;421:277-290.
20. Napoli C, D'Armiento FP, Mancini FP, et al. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia: intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest. 1997;100:2680-2690.
21. Napoli C, de Nigris F, Welch JS, et al. Maternal hypercholesterolemia during pregnancy promotes early atherogenesis in LDL receptor-deficient mice and alters aortic gene expression determined by microarray. Circulation. 2002;105:1360-1367.
22. McGill HC, Geer JC, Homan RL. Sites of vascular vulnerability in dogs demonstrated by Evan blue. Arch Pathol. 1957;64:303-311.
23. Bell FP, Day AJ, Gent M, Schwartz CJ. Differing patterns of cholesterol accumulation and 3-H-cholesterol influx in areas of the cholesterol-fed pig aorta identified by Evans blue dye. Exp Mol Pathol. 1975;22:336-375.
24. 125I-LDL, and parenteral Evans blue dye protein complex along the aortas of normocholesterolemic minipigs as predictors of subsequent hypercholesterolemic atherogenesis. Arterioscler Thromb. 1993;13:1193-1204.
25. Nielsen LB, Nordestgaard BG, Stender S, Kjeldsen K. Aortic permeability to LDL as a predictor of aortic cholesterol accumulation in cholesterol-fed rabbits. Arterioscler Thromb. 1992;12:1402-1409.
26. Berceli SA, Warty VS, Sheppeck RA, Mandarino WA, Tanksale SK, Borovetz HS. Hemodynamics and low density lipoprotein metabolism: rates of low density lipoprotein incorporation and degradation along medial and lateral walls of the rabbit aorto-iliac bifurcation. Arteriosclerosis. 1990;10:686-694.
27. Barakat AI, Uhthoff PA, Colton CK. Topographical mapping of sites of enhanced HRP permeability in the normal rabbit aorta. J Biomech Eng. 1992;114:283-292.
28. Williams KJ, Tabas I. The response to retention hypothesis of atherogenesis reinforced. Curr Opin Lipidol. 1998;9:471-474.
29. Schwenke DC. Metabolic evidence for sequestration of low-density lipoprotein in abdominal aorta of normal rabbits. Am J Physiol Heart Circ Physiol. 2000;279:H1128-H1140.
30. Davies PF, Polacek DC, Shi C, Helmke BP. The convergence of haemodynamics, genomics, and endothelial structure in studies of the focal origin of atherosclerosis. Biorheology. 2002;39:299-306.
31. Davies PF, Zilberg J, Helmke BP. Spatial microstimuli in endothelial mechanosignaling. Circ Res. 2003;92:359-370.
32. Davies PF, Shi C, Depaola N, Helmke BP, Polacek DC. Hemodynamics and the focal origin of atherosclerosis: a spatial approach to endothelial structure, gene expression, and function. Ann N Y Acad Sci. 2001;947:7-16.
33. Garcia-Cardena G, Comander J, Anderson KR, Blackman BR, Gimbrone MA. Biomechanical activation of vascular endothelium as a determinant of its functional phenotype. Proc Natl Acad Sci USA. 2001;98:4478-4485.
34. Chen BP, Li YS, Zhao Y, et al. DNA microarray analysis of gene expression in endothelial cells in response to 24-h shear stress. Physiol Genomics. 2001;7:55-63.
35. Brooks AR, Lelkes PI, Rubanyi GM. Gene expression profiling of human aortic endothelial cells exposed to disturbed flow and steady laminar flow. Physiol Genomics. 2002;9:27-41.
36. Lin T, Zeng L, Liu Y, et al. Rho-ROCK-LIMK-cofilin pathway regulates shear stress activation of sterol regulatory element binding proteins. Circ Res. 2003;92:1296-1304.
37. Liu Y, Chen BPC, Lu M, et al. Shear stress activation of SREBP1 in endothelial cells is mediated by integrins. Arterioscler Thromb Vasc Biol. 2002;22:76-81.
38. Kasus-Jacobi A, Ou J, Bashmakov YK, et al. Characterization of mouse short-chain aldehyde reductase (SCALD), an enzyme regulated by sterol regulatory element-binding proteins. J Biol Chem. 2003;278:32380-32389.
39. Chappell DC, Varner SE, Nerem RM, Medford RM, Alexander RW. Oscillatory shear stress stimulates adhesion molecule expression in cultured human endothelium. Circ Res. 1998;82:532-539.
40. Chiu JJ, Chen LJ, Lee PL, et al. Shear stress inhibits adhesion molecule expression in vascular endothelial cells induced by coculture with smooth muscle cells. Blood. 2003;101:2667-2674.
41. Mohan S, Mohan N, Sprague EA, Differential activation of NF-κB in human aortic endothelial cells conditioned to specific flow environments. Am J Physiol. 1997;273:C572-C578.
42. Mohan S, Hamuro M, Sorescu GP, et al. IκBα-dependent regulation of low-shear flow-induced NF-κB activity: role of nitric oxide. Am J Physiol Cell Physiol. 2003;284:C1039-C1047.
43. Bhullar IS, Li YS, Miao H, et al. Fluid shear stress activation of IκB kinase is integrin-dependent. J Biol Chem. 1998;273:30544-30549.
44. Hajra L, Evans AI, Chen M, Hyduk SJ, Collins T, Cybulsky MI. The NF-κB signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation. Proc Natl Acad Sci U S A. 2000;97:9052-9057.
45. Nakashima Y, Raines EW, Plump AS, Breslow JL, Ross R. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the apoE-deficient mouse. Arterioscler Thromb Vasc Biol. 1998;18:842-851.
46. Uematsu M, Ohara Y, Navas JP, et al. Regulation of endothelial cell nitric oxide synthase mRNA expression by shear stress. Am J Physiol. 1995;269:C1371-C1378.
47. Topper JN, Cai J, Falb D, Gimbrone MA. Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress. Proc Natl Acad Sci U S A. 1996;93:10417-10422.
48. Ziegler T, Bouzourene K, Harrison VJ, Brunner HR, Hayoz D. Influence of oscillatory and unidirectional flow environments on the expression of endothelin and nitric oxide synthase in cultured endothelial cells. Arterioscler Thromb Vasc Biol. 1998;18:686-692.
49. Gallis B, Corthals GL, Goodlett DR, et al. Identification of flow-dependent endothelial nitric-oxide synthase phosphorylation sites by mass spectrometry and regulation of phosphorylation and nitric oxide production by the phosphatidylinositol 3-kinase inhibitor LY294002. J Biol Chem. 1999;274:30101-30108.
50. Shaul PW. Endothelial nitric oxide synthase, caveolae and the development of atherosclerosis. J Physiol. 2003;547:21-33.
51. De Nigris F, Lerman LO, Ignarro SW, et al. Beneficial effects of antioxidants and L-arginine on oxidation-sensitive gene expression and endothelial NO synthase activity at sites of disturbed shear stress. Proc Natl Acad Sci U S A. 2003;100:1420-1425.
52. Park H, Go YM, St John PL, et al. Plasma membrane cholesterol is a key molecule in shear stress-dependent activation of extracellular signal-regulated kinase. J Biol Chem. 1998;273:32304-32311.
53. De Keulenaer GW, Chappell DC, Ishizaka N, Nerem RM, Alexander RW, Griendling KK. Oscillatory and steady laminar shear stress differentially affect human endothelial redox state: role of a superoxide-producing NADH oxidase. Circ Res. 1998;82:1094-1101.
54. Harrison D, Griendling KK, Landmesser U, Hornig B, Drexler H. Role of oxidative stress in atherosclerosis. Am J Cardiol. 2003;91:7A-11A.
55. Sorescu D, Weiss D, Lassegue B, et al. Superoxide production and expression of NOX family proteins in human atherosclerosis. Circulation. 2002;105:1429-1435.
56. Cooke JP. Flow, NO, and atherogenesis. Proc Natl Acad Sci USA. 2003;100:768-770.
57. Lusis AJ. Atherosclerosis. Nature. 2000;407:233-241.
58. Glass CK, Witztum JL. Atherosclerosis: the road ahead. Cell. 2001;104:503-516.
59. Reardon CA, Getz GS. Mouse models of atherosclerosis. Curr Opin Lipidol. 2001;12:167-173.
60. Daugherty A. Mouse models of atherosclerosis. Am J Med Sci. 2002;323:3-10.
61. deWinther MPJ, Hofker MH. New mouse models for lipoprotein metabolism and atherosclerosis. Curr Opin Lipidol. 2002;13:191-197.
62. Fazio S, Linton MF. Mouse models of hyperlipidemia and atherosclerosis. Front Biosci. 2001;6:D515-D525.
63. Tiemann K, Weyer D, Djoufack PC, et al. Increasing myocardial contraction and blood pressure in C57BL/6 mice during early postnatal development. Am J Physiol Heart Circ Physiol. 2003;284:H464-H474.
64. Bassiouny HS, Zarins CK, Lee DC, Skelly CL, Fortunato JE, Glagov S. Diurnal heart rate reactivity: a predictor of severity of experimental coronary and carotid atherosclerosis. J Cardiovasc Risk. 2002;9:331-338.
65. Getz GS. Mouse model of unstable atherosclerotic plaque? Arterioscler Thromb Vasc Biol. 2000;20:2503-2505.
66. Rosenfeld ME, Polinski P, Virmani R, Kauser K, Rubanyi G, Schwartz SM. Advanced atherosclerotic lesions in the innominate artery of the apoE knockout mouse. Arterioscler Thromb Vasc Biol. 2000;20:2587-2592.
67. Johnson JL, Jackson CL. Atherosclerotic plaque rupture in the apolipoprotein E knockout mouse. Atherosclerosis. 2001;154:399-406.
68. Williams H, Johnson JL, Carson KGS, Jackson CL. Characteristics of intact and ruptured atherosclerotic plaques in brachiocephalic arteries of apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol. 2002;22:788-792.
69. Calara F, Silvestre M, Casanada F, Yuan N, Napoli C, Palinski W. Spontaneous plaque rupture and secondary thrombosis in apolipoprotein E-deficient and LDL receptor-deficient mice. J Pathol. 2001;195:257-263.
70. Braun A, Trigatti BL, Post MJ, et al. Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice. Circ Res. 2002;90:270-276.
71. Caligiuri G, Levy B, Pernow J, Thorén P, Hansson GK. Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice. Proc Natl Acad Sci U S A. 1999;96:6920-6924.
72. Yamashita T, Kawashima S, Ozaki M, et al. In vivo angiographic detection of vascular lesions in apolipoprotein E-knockout mice using a synchrotron radiation microangiography system. Circ J. 2002;66:1057-1059.
73. Reardon CA, Blachowicz L, White T, et al. Effect of immune deficiency on lipoproteins and atherosclerosis in male apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2001;21:1011-1016.
74. Tangirala RK, Rubin EM, Palinski W. Quantification of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesion between sexes in the LDL receptor-deficient and apolipoprotein E-deficient mice. J Lipid Res. 1995;36:2320-2328.
75. Methia N, Andre P, Denis CV, Economopoulos M, Wagner DD. Localized reduction of atherosclerosis in von Willebrand factor-deficient mice. Blood. 2001;98:1424-1428.
76. Daugherty A, Whitman SC. Quantification of atherosclerosis in mice. Methods Mol Biol. 2003;209:293-309.
77. Lichtman AH, Clinton SK, Iiyama K, Connelly PW, Libby P, Cybulsky MI. Hyperlipidemia and atherosclerotic lesion development in LDL receptor-deficient mice fed defined semipurified diets with and without cholate. Arterioscler Thromb Vasc Biol. 1999;19:1938-1944.
78. Rudel LL, Kelley K, Sawyer JK, Shah R, Wilson MD. Dietary monoun-saturated fatty acids promote aortic atherosclerosis in LDL receptor-null, human apoB 100-overexpressing transgenic mice. Arterioscler Thromb Vasc Biol. 1998;18:1818-1827.
79. Boisvert WA, Black AS, Curtiss LK. ApoAI reduces free cholesterol accumulation in atherosclerotic lesions of apoE-deficient mice transplanted with apoE-expressing macrophages. Arterioscler Thromb Vasc Biol. 1999;19:525-530.
80. Choudhury RP, Aguinaldo JG, Rong JX, et al. Atherosclerotic lesions in genetically modified mice quantified in vivo by non-invasive high-resolution magnetic resonance microscopy. Atherosclerosis. 2002;162:315-321.
81. Itskovich VV, Choudhury RP, Aguinaldo JG, et al. Characterization of aortic root atherosclerosis in apoE knockout mice: high-resolution in vivo and ex vivo MRM with histological correlation. Magn Reson Med. 2003;49:381-385.
82. Choudhury RP, Fayad ZA, Aguinaldo JG, et al. Serial, noninvasive, in vivo magnetic resonance microscopy detects the development of atherosclerosis in apolipoprotein E-deficient mice and its progression by arterial wall remodeling. J Magn Reson Imaging. 2003;17:184-189.
83. Harats D, Shaish A, George J, et al. Overexpression of 15-lipoxygenase in vascular endothelium accelerates early atherosclerosis in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol. 2000;20:2100-2105.
84. Buono C, Come CE, Stavrakis G, Maguire GF, Connelly PW, Lichtman AH. Influence of interferon-γ on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse. Arterioscler Thromb Vasc Biol. 2003;23:454-460.
85. Shi W, Wang NJ, Shih DM, Sun VZ, Wang X, Lusis AJ. Determinants of atherosclerosis susceptibility in the C3H and C57BL/6 mouse model: evidence for involvement of endothelial cells but not blood cells or cholesterol metabolism, Circ Res. 2000;86:1078-1084.
86. Witting PK, Pettersson K, Letters J, Stocker R. Site-specific antiatherogenic effect of probucol in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2000;20:E26-E33.
87. Schiller NK, Kubo N, Boisvert WA, Curtiss LK. Effect of gamma-irradiation and bone marrow transplantation on atherosclerosis in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol. 2001;21:1674-1680.
88. 2 increases atherosclerotic lesion formation in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol. 2003;23:263-268.
89. Reardon CA, Blachowicz L, Lukens J, Nissenbaum M, Getz GS. Genetic background selectively influences innommate artery atherosclerosis: immune system deficiency as a prode. Anerioscler Thromb Vasc Biol. 2003;23:1449-1454.
90. Thomas SR, Leichtweis SB, Pettersson K, et al. Dietary cosupplementation with vitamin E and coenzyme Q(10) inhibits atherosclerosis in apolipoprotein E gene knockout mice. Arterioscler Thromb Vasc Biol. 2001;21:585-593.
91. Freigang S, Horkko S, Miller E, Witztum JL, Palinski W. Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes. Arterioscler Thromb Vasc Biol. 1998;18:1972-1982.
92. George J, Afek A, Shaish A, et al. 12/15-Lipoxygenase gene disruption attenuates atherogenesis in LDL receptor-deficient mice. Circulation. 2001;104:1646-1650.
93. Tangirala RK, Tsukamoto K, Chun SH, Usher D, Pure E, Rader DJ. Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-1 in mice. Circulation. 1999;100:1816-1822.
94. Song C, Reardon CA, Getz GS, Liao S. Effects of selective liver X receptor agonist on atherosclerosis progression and regression in apoE knock-out mice. Circulation. 2001;104(suppl II):II-329. Abstract.
95. Veniant MM, Pierotti V, Newland D, et al. Susceptibility to atherosclerosis in mice expressing exclusively apolipoprotein B48 or apolipoprotein B 100. J Clin Invest. 1997;100:180-188.
96. -/- mice. J Clin Invest. 2001;108:1513-1522.
97. King VL, Szilvassy SJ, Daugherty A. IL-4 deficiency decreases atherosclerosis formation in female LDL receptor deficient mice. Arterioscler Thromb Vasc Biol. 2002;22:456-461.
98. Babaev VR, Patel MB, Semenkovich CF, Fazio S, Linton MF. Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in low density lipoprotein receptor-deficient mice. J Biol Chem. 2000;275:26293-26299.
99. Duez H, Chao Y, Hernandez M, et al. Reduction of atherosclerosis by the peroxisome proliferator-activated receptor α agonist fenofibrate in mice. J Biol Chem. 2002;277:48051-48057.
100. -/- mice. J Interferon Cytokine Res. 2002;22:661-670.
101. Malek AM, Izumo S. Control of endothelial cell gene expression by flow. J Biomech. 1995;28:1515-1528.
102. Paigen B, Morrow PA, Holmes D, Mitchell D, Williams RA. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis. 1987;68:231-240.
103. Cyrus T, Witztum JL, Rader DJ, et al. Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apoE-deficient mice. J Clin Invest. 1999;103:1597-1604.
104. Cyrus T, Pratico D, Zhao L, et al. Absence of 12/15- lipoxygenase expression decreases lipid peroxidation and atherogenesis in apolipoprotein E-deficient mice. Circulation. 2001;103:2277-2282.
105. Griendling KK, Harrison DG. Out, dammed dot: studies of the NADPH oxidase in atherosclerosis. J Clin Invest. 2001;108:1423-1424.
106. Conrad DJ, Kuhn H, Mulkins M, Highland E, Sigal E. Specific inflammatory cytokines regulate the expression of human monocyte 15-LO. Proc Natl Acad Sci U S A. 1992;89:217-221.
107. Young JL, Libby P, Schönbeck U. Cytokines in the pathogenesis of atherosclerosis. Thromb Haemost. 2002;88:554-567.
108. Colinayo VV, Qiao JH, Demant P, Krass K, Lusis AJ, Drake TA. Genetic characterization of the Dyscalc locus. Mamm Genome. 2002;13:283-288.
109. Smith JB, Wadleigh DJ, Xia YR, Mar RA, Herschman HR, Lusis AJ. Cloning and genomic localization of the murine LPS-induced CXC chemokine (LIX) gene, Scyb5. Immunogenetics. 2002;54:599-603.
110. Mehrabian M, Wong J, Wang X, et al. Genetic locus in mice that block, development of atherosclerosis despite extreme hyperlipidemia. Circ Res. 2001;89:125-130.
111. Smith JD, James D, Dansky HM, Wittkowski KM, Moore KJ, Breslow JL. In silico quantitative trait locus map for atherosclerosis susceptibility in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2003;23:117-122.
112. Dansky HM, Shu P, Donavan M, et al. A phenotype-sensitizing apoE-deficient genetic background reveals novel atherosclerosis predisposition loci in the mouse. Genetics. 2002;160:1599-1608.
113. Welch CL, Bretschger S, Latib N, et al. Localization of atherosclerosis susceptibility loci to chromosomes 4 and 6 using the Ldlr knockout mouse model. Proc Natl Acad Sci U S A. 2001;98:7946-7951.
114. Hodgin JB, Maeda N. Minireview: estrogen and mouse models of atherosclerosis. Endocrinology. 2002;143:4495-4501.
115. Li AC, Brown KK, Silverstre MJ, Wilson TM, Palinski W, Glass CK. Peroxisome proliferator-activated receptor γ ligands inhibit development of atherosclerosis in LDL receptor-deficient mice. J Clin Invest. 2000;106:523-531.
116. Dansky HM, Charlton SA, Harper MM, Smith JD. T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc Natl Acad Sci U S A. 1997;94:4642-4646.
117. Song L, Leung C, Schindler C. Lymphocytes are important in early atherosclerosis. J Clin Invest. 2001;108:251-259.